Ellis Elizabeth, Zhang Kangyi, Lin Qianyu, Ye Enyi, Poma Alessandro, Battaglia Giuseppe, Loh Xian Jun, Lee Tung-Chun
Department of Chemistry, University College London (UCL), UK.
J Mater Chem B. 2017 Jun 21;5(23):4421-4425. doi: 10.1039/c7tb00654c. Epub 2017 May 12.
Drug nanocarriers are synthesised via a facile self-assembly approach using gold nanoparticles (Au NPs) as a structural core. The nanocarriers feature a multilayer shell of POEGMA-PDPA-PMPC triblock copolymers with a chain-end thiol functional group for anchoring to the Au NP surface. This water-soluble triblock copolymer was synthesised via atom transfer radical polymerisation (ATRP) from a bi-functional initiator containing a disulphide bridge. The resultant nanocarriers exhibit high biocompatibility plus excellent colloidal stability and antifouling capability in bio-media (50% PBS/FBS). Encapsulation and release of a hydrophobic drug can be effectively triggered by a pH-stimulus. Meanwhile drug-loaded nanocarriers show enhanced efficacy towards cancer cells compared to plain drug.
药物纳米载体通过一种简便的自组装方法合成,以金纳米颗粒(Au NPs)作为结构核心。这些纳米载体具有由POEGMA - PDPA - PMPC三嵌段共聚物构成的多层壳,其链端带有硫醇官能团,用于锚定在Au NP表面。这种水溶性三嵌段共聚物是通过原子转移自由基聚合(ATRP)从含有二硫键的双功能引发剂合成的。所得的纳米载体在生物介质(50% PBS/FBS)中表现出高生物相容性以及出色的胶体稳定性和抗污能力。疏水性药物的包封和释放可通过pH刺激有效触发。同时,与普通药物相比,载药纳米载体对癌细胞显示出更高的疗效。